NCT05663281

Brief Summary

In the present study, the investigators use high-resolution MR vessel wall imaging, and select patients with cerebral and cervical artery occlusion to investigate the relationship between the imaging appearance of thrombus and the various outcome of recanalization treatment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
15mo left

Started Dec 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Dec 2022Dec 2027

First Submitted

Initial submission to the registry

December 15, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

December 15, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 23, 2022

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

July 3, 2024

Status Verified

June 1, 2024

Enrollment Period

5 years

First QC Date

December 15, 2022

Last Update Submit

June 30, 2024

Conditions

Keywords

ThrombusNeuroimagingHigh-resolution vessel wall imagingCerebral ischemiaCerebral artery

Outcome Measures

Primary Outcomes (2)

  • Rate of Successful Recanalization

    Antegrade blood flow through the recanalized portion was assessed by thrombolysis in myocardial infarction (TIMI) score or thrombolysis in cerebral infarction (TICI) score. TIMI≥2 or TICI≥2b was defined as successful recanalization.

    1-3 Years

  • Ischemic Stroke Occurrence

    Ischemic stroke occurrence during follow-up period which was confirmed by neuroimaging

    1-3 Years

Secondary Outcomes (1)

  • Number of Participants with Adverse Events

    1-3 Years

Interventions

Imaging appearance of intracranial and/or extracranial arterial thrombus

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Participants who are confirmed to have extracranial and/or intracranial artery occlusion

You may qualify if:

  • Age ≥ 18 years
  • Extracranial and/or intracranial artery occlusion confirmed by angiography
  • Available for magnetic resonance high-resolution vessel wall imaging
  • Written informed consent obtained

You may not qualify if:

  • Extracranial and/or intracranial artery mild to moderate stenosis
  • Pregnant women
  • Restenosis or occlusion after artery stenting placement

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chinese PLA General Hospital

Beijing, Beijing Municipality, 100853, China

RECRUITING

MeSH Terms

Conditions

Intracranial ThrombosisThrombosisBrain Ischemia

Condition Hierarchy (Ancestors)

Intracranial Embolism and ThrombosisCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesThromboembolismEmbolism and Thrombosis

Central Study Contacts

Jinhao Lyu, M.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending physician

Study Record Dates

First Submitted

December 15, 2022

First Posted

December 23, 2022

Study Start

December 15, 2022

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

July 3, 2024

Record last verified: 2024-06

Locations